Affimed Announces Addition to NASDAQ Biotechnology Index

17. Dezember 2019 INDIZES USA

Heidelberg, Germany, December 17, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...